America’s becalmed bond market

The world’s continuing quantitative easing programmes have contributed to the lack of volatility in the US Treasury bond market, which is at a three-year low.

The eerie calm in stockmarkets has hogged the headlines of late, but "equities are not the only becalmed asset class", notes Robin Wigglesworth in the Financial Times. The Move index, used to measure the implied volatility of the US Treasury market, is now at a three-year low. "This looks peculiar." US government debt is "subject to fierce cross-currents that should arguably produce some turbulence".

On the one hand, "there is plenty to back bullish views", as Scott Dorf points out on Bloomberg. In a world of low and even negative interest rates, investors remain hungry for yield and although the 2.2% offered by ten-year Treasuries looks pathetic, compared to their German counterpart yielding 0.35%, it's well worth buying.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Andrew Van Sickle
Editor, MoneyWeek

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.